From the Department of Anaesthesiology and Operative Intensive Care (Dr. Reinhart), Friedrich-Schiller-University, Jena, Germany; Steglitz University Medical Centre (Dr. Wiegand-Lohnert), Berlin, Germany; Department of Medicine (Dr. Grimminger), University of GieBen, Germany; Department of Clinical Research (Drs. Kaul, Kempeni, and Daum, and Mr. Eiselstein), Knoll AG Ludwigshafen, Germany; Department of Anaesthesiology (Dr. Withington), Royal London Hospital, UK; Department of Intensive Care Medicine (Dr. Treacher), St. Thomas Hospital, London, UK; Department of Anaesthesiology (Dr. Eckart), Medical Centre, Augsburg, Germany; Intensive Therapy Unit (Dr. Willatts), Bristol Royal Infirmary, UK; Department of Intensive Care Medicine (Dr. Bouza), Hospital Gregorio Maranon, Madrid, Spain; Department of Anaesthesiology (Dr. Krausch), Charite, Berlin, Germany; and the Intensive Care Unit of 4th Medical Department (Dr. Stockenhuber), AKH, Vienna, Austria.
*Members of the MAK 195F Study Group are listed on page 742.
Supported by a grant from Knoll AG, Ludwigshafen, Germany, a unit of BASF Pharma.
Address requests for reprints to: Konrad Reinhart, MD, Klinik Anasthesiologie, und Intensivtherapie, Friedrich-Schiller-Universitat, 07740 Jena, Germany.